PROTACS as a novel therapeutic strategy in colorectal cancer

    NAME A/Prof Joseph Rosenbluh
    CANCER TYPE General
    INSTITUTION Monash University
    STATE Victoria
    GRANT TYPE $100,000
    PROJECT TYPE Research

    PROTACS as a novel therapeutic strategy in colorectal cancer

    "We will utilise a new and innovative drug development approach called proteolysis targeting chimera (PROTAC)...By combining our expertise in chemistry, cancer genetics and modelling we will develop PROTACs that target and destroy colorectal driving oncogenes. This will enable a new strategy for colorectal cancer treatment."

    - Professor Joseph Rosenbluh, Monash University